Reauthorization of Critical Path Public-Private Partnerships
This bill amends the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships. It increases the authorization of appropriations from $6,000,000 to $10,000,000 for each fiscal year from 2023 through 2027.
Key points
Increases authorized annual funding for the partnerships from $6 million to $10 million.
Sets the funding authorization period for fiscal years 2023 through 2027.
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens
(explained here).
Start recording it now.